Steroid refractory dermatomyositis following combination dabrafenib and trametinib therapy

Research output: Contribution to journalArticle

Authors

Abstract

Rheumatology key message:

Autoimmune events may arise following therapy with MAPK/ERK pathway inhibitors.

Details

Original languageEnglish
JournalRheumatology (Oxford)
Early online date30 Mar 2018
Publication statusE-pub ahead of print - 30 Mar 2018